Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort
Open Access
- 1 February 2016
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 23 (2) , 104-116
Abstract
IgG antibodies to Plasmodium falciparum are transferred from the maternal to fetal circulation during pregnancy, wane after birth, and are subsequently acquired in response to natural infection. We examined the dynamics of malaria antibody responses of 84 Kenyan infants from birth to 36 months of age by (i) serology, (ii) variant surface antigen (VSA) assay, (iii) growth inhibitory activity (GIA), and (iv) invasion inhibition assays (IIA) specific for merozoite surface protein 1 (MSP1) and sialic acid-dependent invasion pathway. Maternal antibodies in each of these four categories were detected in cord blood and decreased to their lowest level by approximately 6 months of age. Serologic antibodies to 3 preerythrocytic and 10 blood-stage antigens subsequently increased, reaching peak prevalence by 36 months. In contrast, antibodies measured by VSA, GIA, and IIA remained low even up to 36 months. Infants sensitized to P. falciparum in utero , defined by cord blood lymphocyte recall responses to malaria antigens, acquired antimalarial antibodies at the same rate as those who were not sensitized in utero , indicating that fetal exposure to malaria antigens did not affect subsequent infant antimalarial responses. Infants with detectable serologic antibodies at 12 months of age had an increased risk of P. falciparum infection during the subsequent 24 months. We conclude that serologic measures of antimalarial antibodies in children 36 months of age or younger represent biomarkers of malaria exposure rather than protection and that functional antibodies develop after 36 months of age in this population.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI098511)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI064667)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI09519)
This publication has 92 references indexed in Scilit:
- Age-Dependent IgG Subclass Responses to Plasmodium falciparum EBA-175 Are Differentially Associated with Incidence of Malaria in Mozambican ChildrenClinical and Vaccine Immunology, 2012
- Allelic Diversity and Naturally Acquired Allele-Specific Antibody Responses to Plasmodium falciparum Apical Membrane Antigen 1 in KenyaInfection and Immunity, 2010
- In VitroGrowth-Inhibitory Activity and Malaria Risk in a Cohort Study in MaliInfection and Immunity, 2010
- Acquisition of antibody isotypes againstPlasmodium falciparumblood stage antigens in a birth cohortParasite Immunology, 2010
- Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition AssayClinical and Vaccine Immunology, 2009
- Serological evidence for long-term epstein-barr virus reactivation in children living in a holoendemic malaria region of KenyaJournal of Medical Virology, 2009
- Acquired Immunity to MalariaClinical Microbiology Reviews, 2009
- Differences in Human Antibody Reactivity to Plasmodium falciparum Variant Surface Antigens Are Dependent on Age and Malaria Transmission Intensity in Northeastern TanzaniaInfection and Immunity, 2008
- Multiplex Assay for Simultaneous Measurement of Antibodies to Multiple Plasmodium falciparum AntigensClinical and Vaccine Immunology, 2006
- Immunity to RecombinantPlasmodium falciparumMerozoite Surface Protein 1 (MSP1): Protection inAotus nancymaiMonkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory ActivityInfection and Immunity, 2006